Surgical management of chronic hyperplastic candidiasis refractory to systemic antifungal treatment
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Surgical management of chronic hyperplastic candidiasis refractory to systemic antifungal treatment ; volume:9 ; number:02 ; year:2017 ; pages:136-139
Journal of laboratory physicians ; 9, Heft 02 (2017), 136-139
- Beteiligte Personen und Organisationen
-
Shah, Neha
Ray, Jay Gopal
Kundu, Sanchita
Sardana, Divesh
- DOI
-
10.4103/0974-2727.199622
- URN
-
urn:nbn:de:101:1-2020041708335555547295
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Shah, Neha
- Ray, Jay Gopal
- Kundu, Sanchita
- Sardana, Divesh
Ähnliche Objekte (12)
Invasive pseudomembranous upper airway and tracheal Aspergillosis refractory to systemic antifungal therapy and serial surgical debridement in an Immunocompetent patient
Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis
Antifungal activity of the piroctone olamine in experimental intra-abdominal candidiasis
Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern
Three-Dose Antifungal Treatment Improves the Efficacy for Severe Vulvovaginal Candidiasis
Appropriate Source Control and Antifungal Therapy are Associated with Improved Survival in Critically Ill Surgical Patients with Intra-abdominal Candidiasis
Hospital use of systemic antifungal drugs
Correction to: Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis
Myeloid cell deficiency of p38γ/p38δ protects against candidiasis and regulates antifungal immunity
Antifungal Effect of Long Noncoding RNA 9708-1 in the Vulvovaginal Candidiasis Murine Model
Plumieride as a novel anti-fungal and anti-inflammatory iridoid against superficial candidiasis in mice
Design and evaluation of antifungal vaginal suppository using coconut oil as base for vulvovaginal candidiasis
Invasive pseudomembranous upper airway and tracheal Aspergillosis refractory to systemic antifungal therapy and serial surgical debridement in an Immunocompetent patient
Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis
Antifungal activity of the piroctone olamine in experimental intra-abdominal candidiasis
Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern
Three-Dose Antifungal Treatment Improves the Efficacy for Severe Vulvovaginal Candidiasis
Appropriate Source Control and Antifungal Therapy are Associated with Improved Survival in Critically Ill Surgical Patients with Intra-abdominal Candidiasis
Hospital use of systemic antifungal drugs
Correction to: Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis
Myeloid cell deficiency of p38γ/p38δ protects against candidiasis and regulates antifungal immunity
Antifungal Effect of Long Noncoding RNA 9708-1 in the Vulvovaginal Candidiasis Murine Model
Plumieride as a novel anti-fungal and anti-inflammatory iridoid against superficial candidiasis in mice
Design and evaluation of antifungal vaginal suppository using coconut oil as base for vulvovaginal candidiasis
Invasive pseudomembranous upper airway and tracheal Aspergillosis refractory to systemic antifungal therapy and serial surgical debridement in an Immunocompetent patient
Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis
Antifungal activity of the piroctone olamine in experimental intra-abdominal candidiasis
Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern
Three-Dose Antifungal Treatment Improves the Efficacy for Severe Vulvovaginal Candidiasis
Appropriate Source Control and Antifungal Therapy are Associated with Improved Survival in Critically Ill Surgical Patients with Intra-abdominal Candidiasis
Hospital use of systemic antifungal drugs
Correction to: Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis
Myeloid cell deficiency of p38γ/p38δ protects against candidiasis and regulates antifungal immunity
Antifungal Effect of Long Noncoding RNA 9708-1 in the Vulvovaginal Candidiasis Murine Model
Plumieride as a novel anti-fungal and anti-inflammatory iridoid against superficial candidiasis in mice